The waiting is the hardest part: The Tipline for 3 October 2017

03 October 2017

Today’s briefing is heavier than usual on California, but the feds are busy too. In addition to putting an early end to the waiting period for more than a dozen deals, the US antitrust agencies settled another merger with remedies and continue to litigate against drugmakers.

Subscribe to Global Competition Review

Subscribe and start reading now

Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.

Subscribe now

Already have access? Login below

Get unlimited access to all Global Competition Review content